Fosinopril Related Compound B (15 mg) ((4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-D-proline propionate (ester), hemibarium salt, sesquihydrate)

 化学構造式
CAS番号.
化学名:
别名:
英語名:
Fosinopril Related Compound B (15 mg) ((4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-D-proline propionate (ester), hemibarium salt, sesquihydrate)
英語别名:
Fosinopril Related Compound B (15 mg) ((4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-D-proline propionate (ester), hemibarium salt, sesquihydrate)
CBNumber:
CB42567479
化学式:
分子量:
0
MOL File:
Mol file

Fosinopril Related Compound B (15 mg) ((4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-D-proline propionate (ester), hemibarium salt, sesquihydrate) 物理性質

安全性情報

Fosinopril Related Compound B (15 mg) ((4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-D-proline propionate (ester), hemibarium salt, sesquihydrate) 価格

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入

Fosinopril Related Compound B (15 mg) ((4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-D-proline propionate (ester), hemibarium salt, sesquihydrate) 化学特性,用途語,生産方法

Fosinopril Related Compound B (15 mg) ((4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-D-proline propionate (ester), hemibarium salt, sesquihydrate) 上流と下流の製品情報

原材料

準備製品


Fosinopril Related Compound B (15 mg) ((4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-D-proline propionate (ester), hemibarium salt, sesquihydrate) 生産企業

Global( 1)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
Whyte Chemicals --
sales@whytechemicals.co.uk United Kingdom 3755 50

  • Fosinopril Related Compound B (15 mg) ((4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-D-proline propionate (ester), hemibarium salt, sesquihydrate)
Copyright 2017 © ChemicalBook. All rights reserved